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Mutations in the Aptx gene lead to a neurological disorder
known as ataxia oculomotor apraxia-1. The product of Aptx is
Aprataxin (Aptx), a DNA-binding protein that resolves abortive
DNA ligation intermediates. Aprataxin catalyzes the nucleo-
philic release of adenylate groups covalently linked to 5 phos-
phate termini, resulting in termini that can again serve as sub-
strates for DNA ligases. Here we show that Aprataxin acts
preferentially on adenylated nicks and double-strand breaks
rather than on single-stranded DNA. Moreover, we show that
whereas the catalytic activity of Aptx resides within the HIT
domain, the C-terminal zinc finger domain provides stabilizing
contacts that lock the enzyme onto its high affinity AMP-DNA
target site. Both domains are therefore required for efficient
AMP-DNA hydrolase activity. Additionally, we find a role for
Aprataxin in base excision repair, specifically in the removal of
adenylates that arise from abortive ligation reactions that take
place at incised abasic sites in DNA.We suggest that Aprataxin
may have a general proofreading function in DNA repair,
removing DNA adenylates as they arise during single-strand
break repair, double-strand break repair, and in base excision
repair.
Ataxia oculomotor apraxia-1 (AOA1)4 is a human autosomal
recessive syndrome whose clinical features include early onset
cerebellar ataxia, oculomotor apraxia, and late peripheral neu-
ropathy (1). The cause of AOA1 is linked tomutations in a gene
that encodes a 342-amino acid protein called Aprataxin (2, 3).
Aptx-defective cell lines are sensitive to DNA-damaging agents
such as methyl methanesulfonate, hydrogen peroxide, and
camptothecin (4–7), indicating a role for Aprataxin in DNA
repair. Recently, it was shown that Aprataxin resolves abortive
DNA ligation intermediates (8), such as those that arise at
“dirty” single-strand breaks formed by oxygen radical attack.
Abortive ligation leads to the covalent attachment of an AMP
moiety to the 5 terminus at the break site. Aprataxin repairs
these lesions by catalyzing the nucleophilic release of 5-adeny-
late groups from the single-strand breaks, resulting in the res-
toration of 5 phosphate termini that can be efficiently rejoined.
Aprataxin protein has three distinct domains: an N-terminal
FHA domain, a central histidine triad (HIT) domain, and a
C-terminal domain with a zinc finger motif (3). The FHA
domainmediates the association of Aprataxin with two distinct
DNA repair complexes, as it specifically interacts with XRCC1
and XRCC4 (4–6, 9). The catalytic HIT domain (Fig. 1A, upper
sequence) is responsible for adenylate hydrolase activity (8, 10),
which is abolished by amutation in the histidine triadmotif (8).
Finally, although the C-terminal domain of Aprataxin has been
implicated in possessing general DNA binding capacity (11),
the importance of the zinc finger motif (lower sequence) for
DNA binding, DNA adenylate binding, and DNA de-adenyla-
tion activity has not been addressed. Here, we define the sub-
strate specificity of Aptx and show that the zinc finger motif
plays an important role in DNA adenylate recognition and
hydrolysis. Furthermore, we show that Aptx fulfills amore gen-
eral proofreading function in DNA repair, extending beyond
the repair of dirty oxidative single-strand breaks.
EXPERIMENTAL PROCEDURES
Proteins—Human Aprataxin was PCR-amplified from a
HeLa cDNA library (Invitrogen) and cloned into pET41 using
the SpeI and BamHI restriction sites. This plasmid expressed
recombinant Aptx with an N-terminal GST and a C-terminal
His8 tag. The mutants AptxH260A, AptxC319A,C322A, and
AptxH260A,C319A,C322Awere generated using theQuikChange II
site-directed mutagenesis kit (Stratagene). Wild-type and
mutant GSTAprataxinHis proteins were expressed in Esche-
richia coli BL21-CodonPlus RIL cells at 30 °C for 2 h following
induction with 0.2 mM isopropyl-1-thio--D-galactopyrano-
side. Cells were lysed and Aprataxin purified using nickel-ni-
trilotriacetic acid-agarose (Qiagen) and glutathione-Sepharose
(GE Healthcare).
Recombinant human DNA ligase III-XRCC1 complex was a
gift from Dr. Tomas Lindahl. T4 DNA ligase was from New
EnglandBiolabs and humanDNApolymerase fromTrevigen.
DNA Substrates—Oligo 1, 5-ATTCCGATAGTGACTACA-
3; oligo 2, 5-TGTAGTCACTATCGGAATGAGGGCGACA-
CGGATATG-3; oligo 3, 5-CATATCCGTGTCGCCCTC-3;
oligo 4, 5-CATATCCGTGTCGCCCTCATTCCGATAGTG-
ACTACA-3; oligo 5, 5-TGTAGTCACTATCGGAAT-3; and
abasic oligo 1 with a 5-deoxyribosephosphate (dRP) residue,
5-dRP-TTCCGATAGTGACTACA-3, were purchased from
Sigma and purified by denaturing gel electrophoresis. 5-32P
labeling was carried out using T4 polynucleotide kinase (New
England Biolabs) and [-32P]ATP (GE Healthcare). Terminal
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deoxynucleotidyl transferase (New England Biolabs) and
[-32P]ddATP (GE Healthcare) were used for 3-32P labeling.
5-32P-labeled oligo 4, alone or annealed to oligo 2, was used
in DNA binding assays. The nicked substrate was prepared by
annealing 5-32P-labeled oligo 1 with oligos 2 and 3. 5-32P-
labeled oligo 1 was adenylated as described (8), purified and
used as AMP-single-stranded DNA, or annealed with oligo 5 to
create AMP-double-stranded DNA or oligos 2 and 3 to create
AMP-nicked DNA.
For the abasic nickedDNAsubstrate, abasic oligo 1was 3-la-
beled using [32P]ddATP and annealed with oligos 2 and 3. The
abasic nicked DNA was then adenylated with human DNA
ligase III-XRCC1, and the adenylated 18dRP oligo1 was repuri-
fied and annealedwith oligos 2 and 3 to form the final substrate.
For the nicked control, oligo 1 (in this case synthesized with a
terminal 5-phosphate) was 3-32P-labeled and the adenylated
nicked substrate was prepared essentially as described (8).
Ligation Reactions—Reactions (5l) containedDNA (50 nM)
and 5 nMDNA ligaseIII-XRCC1, or 20 nM T4 DNA ligase, in 50
mMTris-HCl, pH 7.5, 100mMNaCl, 10mMMgCl2, 5 mMDTT,
25g/ml bovine serum albumin, 1mMATP. After 1 or 2min of
incubation at 37 °C, reactions were stopped by addition of
formamide and heated for 3 min at 90 °C. Products were ana-
lyzed by 10% denaturing PAGE, and 32P-labeled DNA products
were detected by autoradiography.
DNA Adenylate Hydrolysis—Unless stated otherwise, reac-
tions (10 l) contained DNA (50 nM) and recombinant
Aprataxin in 50 mM Tris-HCl, pH 8.0, 40 mM NaCl, 5 mM
EDTA, 1 mM DTT, 100 g/ml bovine serum albumin, and 5%
glycerol. Incubation was for 2 min at room temperature. Reac-
tions were stopped by addition of formamide loading buffer,
and denatured DNA was analyzed by 10% denaturing PAGE
followed by autoradiography. For time course experiments,
reactions (25 l) contained 50 nM DNA and 0.2 nM Aptx. DNA
was analyzed by 10% denaturing PAGE and quantified using a
Storm 840 phosphorimaging system (GE Healthcare). Hydrol-
ysis reactions using whole cell extracts were performed as
described (8) in a buffer containing 50mMTris-HCl, pH 8.0, 40
mM NaCl, 10 mM MgCl2, 1 mM DTT, 100 g/ml bovine serum
albumin, and 5% glycerol.
DNA Binding Assays—Binding reactions (15 l) contained
DNA (50 nM) and Aprataxin in 50mMTris-HCl, pH 8.0, 30 mM
NaCl, 5 mM EDTA, 1 mM DTT, 100 g/ml bovine serum albu-
min, and 5%glycerol.Where indicated, reactions contained 300
ng of poly[dIdC]. Incubation was for 10 min at room tempera-
ture. Reactions were then put on ice and analyzed immediately
by 4% non-denaturing PAGE using 0.5 Tris borate-EDTA as
the running buffer at 4 °C followed by autoradiography.
RESULTS
Substrate Specificity of Aprataxin—It was shown previously
that Aprataxin acts upon adenylated nicked duplex DNA to
remove covalently bound AMP, leaving a 5-phosphate at the
nick that can be ligated to a proximal 3-OH group (8). To
further characterize theDNAde-adenylation activity of human
Aprataxin and to define the specific contribution of each
domain of the protein, we used a mutational analysis approach
to produce four forms of Aprataxin: 1) the wild-type protein
(Aptx), 2) an active site mutant AptxH260A with a non-func-
tional HIT domain, 3) AptxC319A,322A, which is mutated for the
critical cysteine residues in the putative C-terminal zinc finger
motif, and 4) AptxH260A,319A,322A, in which the mutation in the
active site HIT domain is combined with mutations in the zinc
fingermotif (Fig. 1,A andB). For direct comparison, all proteins
carried anN-terminalGST tag and aC-terminalHis8 tag, which
allowed their purification to near homogeneity (Fig. 1C). They
will hereafter be referred to by their protein name and respec-
tivemutation(s). Control experiments have shown that the spe-
cific activity of GST- and His-tagged wild-type Aprataxin on
FIGURE 1. Substrate specificity of Aprataxin. A, ClustalW alignment of the
amino acid sequences comprising the conserved active site histidine triad
motif (HXHXH, upper panel) and C-terminal zinc finger motif (C2H2; lower
panel) of Aprataxin orthologs from human (Hs, Homo sapiens), mouse (Mm,
Musmusculus), fish (Dr,Danio rerio), plant (At, Arabidopsis thaliana), and yeast
(Sc, Saccharomyces cerevisiae). Conserved and similar amino acids are indi-
cated by black and gray shadings, respectively. B, schematic representation of
Aptx proteins used in this study highlighting the tripartite domain structure.
The wild-type protein (1) contains an N-terminal FHA domain, a central histi-
dine triad domain (HIT), and a C-terminal domain with a zinc finger motif (Z).
Mutant proteins were created to disrupt the HIT domain (2) (AptxH260A), the
zinc finger motif (3) (AptxC319A,C322A), and both domains simultaneously (4)
(AptxH260A,C319A,C322A). C, four N-terminal GST- and C-terminal His-tagged
Aprataxin proteins (0.3 g/lane) were purified using nickel-nitrilotriacetic
acid-agarose and glutathione-Sepharose. They were then analyzed by SDS-
PAGE followed by Coomassie blue staining. Lane numbers correspond to the
proteins indicated in panel B. Lane M, molecular mass markers (kDa). The
GSTAptxHis proteins have an apparent molecular mass of60 kDa. D, activity
of Aptx on adenylated single- and double-stranded linear DNA and adeny-
lated nicked duplex DNA. Products were analyzed by denaturing PAGE and
detected by autoradiography. 5-32P labels are indicated with asterisks.
E, quantification of Aptx activity on adenylated single-stranded (open trian-
gles), double-stranded linear (filled triangles), and nicked duplex (circles) DNA
under limiting enzyme concentrations.
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adenylated DNA is comparable with that of untagged
Aprataxin (data not shown).
First, we compared the activity of wild-type Aprataxin on
single- and double-stranded DNA. In these experiments, each
substrate contained the same 32P-labeled adenylated 18-mer
oligonucleotide, and de-adenylation was monitored by its
increased mobility through a denaturing gel following removal
of covalently boundAMP.We found that Aprataxin acted pref-
erentially on duplex DNA containing an adenylate residue at
the 5 terminus of a nick (Fig. 1D, lanes 9–12) or double-strand
break (lanes 5–8) compared with adenylated single-stranded
DNA (lanes 1–4). Time course experiments using limiting
enzyme concentrations showed that the de-adenylation activity
with double-stranded DNA was 3 greater than that
observed with single-stranded DNA (Fig. 1E).
To determinewhether Aprataxin exhibits a different binding
affinity for the various DNAs, we carried out electrophoretic
mobility shift assays. Aprataxin bound linear (Fig. 2, lanes 6–8)
or nicked (lanes 10–12) duplex DNAmore tightly than single-
stranded DNA (lanes 2–4), consistent with previous studies
(11).
When electrophoretic mobility shift assays were carried out
using nicked duplex DNA substrates, we observed three dis-
tinct protein-DNA complexes (designated I, II, and III). These
complexes were observed with both nicked duplex (Fig. 3, lanes
2–4) and adenylated nicked duplex (lanes 15–17) DNA. Given
thatAprataxin is catalytically active under the conditions of this
assay and de-adenylation occurs (data not shown), it was nec-
essary to carry out similar reactionswithAptxH260A, containing
an inactivating mutation in the HIT domain. Using AptxH260A
we observed enhanced complex formation with the nicked
adenylated substrate (compare lanes 8–10 with lanes 21–23).
Furthermore, in contrast to complexes formed by wild-type
Aptx, we found that the protein-DNA complexes formed
betweenAptxH260A and the adenylated substrate were resistant
to competition with a 30-fold excess of poly[dIdC] (lanes
24–26). We also found that the poly[dIdC] converted com-
plexes III and II to the least retarded complex I. Control reac-
tions with catalytically active Aptx, and with AptxH260A and
unadenylated nicked duplex DNA, showed that complex for-
mation was competed away by the presence of poly[dIdC]
(lanes 5–7, 11–13, and 18–20). Based on these results, we sug-
gest that complex I represents Aprataxin bound at the site of
the nick, an interaction that is stabilized by the adenylate moi-
ety, and that complexes II and III are formed by the binding of
Aprataxin to flanking regions of
DNA. Poly[dIdC] competes away
the general DNA binding but is
unable to disrupt the specific com-
plex formed between catalytically
inactive AptxH260A and its target,
the adenylated residue.
These results show that Aprataxin
has the ability to bind duplex
DNA, possibly enabling the pro-
tein to scan the genome for sites of
adenylation. When such a site is
encountered, Aprataxin forms a
high affinity complex that (with
wild-type protein) leads to rapid
de-adenylation.
Binding of Aptx to Duplex DNA
Is Mediated by the C-terminal
Zinc Finger—To date, the precise
role of the putative zinc finger
motif of Aprataxin has not been
established.We therefore assessed
the contribution of the zinc finger
FIGURE 2.DNA binding by Aprataxin. Reactions contained single-stranded
DNA, double-stranded DNA, or nicked DNA and Aprataxin (50, 250, and 500
nM) as indicated. Protein-DNA complexes were analyzed by electrophoretic
mobility shift assay and detected by autoradiography. Roman numeralsmark
the position of three distinct protein-DNA complexes.
FIGURE3.Specific interactionofAprataxinwithadenylatedresidues.Reactionscontainedthe indicatednicked
or adenylated nicked substrates and either wild-type or catalytically inactive AptxH260A (50, 250, and 500 nM).
Poly[dIdC]was presentwhere indicated. Protein-DNA complexeswere analyzed as described in Fig. 2 legend.
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to DNA binding by carrying out site-directed mutagenesis to
convert the zinc-coordinating cysteines (residues Cys-319
and Cys-322) to alanine. A comparison of AptxH260A with
AptxH260A,C319A,C322A showed that disruption of the zinc
finger resulted in a significant loss of DNA binding activity
(Fig. 4A, lanes 3 and 6). Similar results were obtained with
AptxH260A,C319A,C322A and the nicked DNA adenylate,
although in this case some residual binding was observed
(lanes 9 and 12). Residual binding to the nicked adenylated
DNA resulted in the formation of complex I only, indicating
that this complex results from a specific interaction with the
adenylated residue at the nick.
Taken together, the results shown in Figs. 3 and 4 show that
Aprataxin forms a stable complex with nicked adenylatedDNA
that is resistant to competition when challenged by excess
duplex DNA. The stability of this complex is dependent upon
the C-terminal zinc finger of the protein.
Efficient De-adenylation Requires the Zinc Finger Motif—
When the zinc finger mutant AptxC319A,C322A was analyzed for
its ability to promote de-adenylation, we observed a near 100-
fold reduction in activity compared with wild-type Aprataxin
(Fig. 4B). This result demonstrates that the zinc finger
domain is important for efficient hydrolysis of DNA adeny-
lates. Even though the catalytic domain of AptxC319A,C322A is
intact, the loss of its zinc finger DNA binding module ren-
ders Aptx inefficient.
Adenylated Abasic Nicks Constitute a Novel Substrate for
Aptx—Previously, we showed that Aprataxin acts upon nicked
adenylated DNA substrates such as those that might be pro-
duced by abortive ligation reactions that take place at sites of
oxidative damage (8). An additional and important target sub-
strate might also arise from premature ligation of nicked abasic
sites (AP sites) resulting from the removal of damaged bases by
monofunctional DNA glycosylases such as human UNG,
SMUG-1,MPG, TDG, andMYH, followed byAP endonuclease
1 incision. To test this hypothesis, we first determined whether
abortive ligation reactions occurred at base excision repair
(BER) intermediates and therefore synthesized a model sub-
strate with a dRP residue at the 5 terminus of the nick. When
incubated with human DNA ligase III-XRCC1 complex, we
found that ligation of the abasic nick took place (Fig. 5A, lanes
2–3) with an efficiency that was 5–10 times below that
observed with normal nicked DNA (lanes 7–8 and data not
shown). Similar results were observed with T4 DNA ligase
(lanes 4–5 and 9–10) as described previously (12, 13). How-
ever, in reactions containing human DNA ligase III-XRCC1
and the abasic substrate, we also observed abortive ligation
reactions culminating in the accumulation of DNA adenylates
(indicated as AMP-18dRP in Fig. 5A, lanes 2–3).
To test whether these DNA adenylates lacking a 5-terminal
base at the nick serve as a substrate for Aptx, ligation reactions
with human DNA ligase III-XRCC1 were supplemented with
Aptx (Fig. 5B). In these reactions, we did not observe the pres-
ence of anyDNAadenylates but instead observed an increase in
ligation products (lane 3). These results indicate that without
the actions of Aprataxin, abortive ligation events at BER inter-
mediates could lead to a relatively high incidence of DNA
adenylate formation.
When the efficiency of AMP hydrolysis by Aprataxin at nor-
mal and abasic nicks was compared, we found that the abasic
DNA adenylate served as a substrate for Aptx and was hydro-
lyzed with an efficiency that was 5 times lower than that
observed with normal adenylated nicked DNA (Fig. 5C, com-
pare lanes 2–4with 6–8). Taken together, these data lead us to
suggest that abortive ligation reactions that take place at BER
intermediates may require Aprataxin for efficient repair and
restoration of the DNA backbone. This notion is supported by
the observation that adenylated abasic nicks persist in whole
cell extracts prepared from theAOA1patient cell lines Ap1 and
Ap3 (Fig. 5D, lanes 3 and 4), while AMP hydrolysis can be
observed in normal extracts (lane 2). In agreement with this, we
found that human DNA polymerase , which is known to add
dNTPs to 3 termini at dRP sites (14), is unable to utilize its lyase
activity to remove adenylated dRP termini (Fig. 5E, lane 2).
DISCUSSION
In this workwe have shown that Aprataxin forms specific com-
plexes with nicked adenylated DNA and promotes the repair and
restoration of 5 termini that are adenylated by abortive ligation
reactions.The actionsofAprataxin are essential innon-replicative
cells, such as neuronal cells, which otherwise as a consequence of
oxidative damage would accumulate adenylates that may pose a
block to the transcriptionalmachinery.Analysesof theDNAbind-
ing capacity of Aprataxin revealed that the protein binds undam-
FIGURE 4. The zinc finger motif of Aptx is required for substrate recogni-
tion and hydrolysis. A, electrophoretic mobility shift assay reactions con-
tainedwild-typeormutantAptx and linear, nicked, or adenylatednickedDNA
as indicated. Poly[dIdC]was included in the reactions of lanes 10–12. Protein-
DNA complexes were analyzed as described in the Fig. 2 legend. B, DNA de-
adenylation reactions contained wild-type Aptx or the zinc finger mutant
AptxC319A,C322A with adenylated nicked duplex DNA. Products were analyzed
by denaturing PAGE and detected by autoradiography.
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aged duplex DNA in agreement with previous observations (11).
However, competition studies using catalytically inactive
AptxH260A showed that the protein forms a specific and stable
complex with nicked adenylated duplex DNA. The binding and
de-adenylation of single-stranded DNA was less than that
observed with duplex substrates.
As far as we are aware, Aprataxin is the only enzyme capable of
de-adenylating AMP-DNA substrates. However, like other mem-
bersof theHITsuperfamily,Aprataxin canactuponAMP-NH2or
AppppA,but thecatalytic activityobservedwith these substrates is
3–4 orders of magnitude less than that observed with adenylated
DNA (8, 11). It is therefore our opinion that the neurological dis-
order (AOA1) associated with Aprataxin loss relates to the loss of
DNA de-adenylation activity.
Taken together with our previous observations (8), the data
presented here indicate that adenylates present in duplex DNA
are the physiological substrates for Aprataxin. The specific
action of Aptx on damaged duplex DNA is consistent with
observations showing that Aptx associates with the DNA ligase
III-XRCC1 and DNA ligase IV-XRCC4 complexes (4, 6). Our
finding that Aptx hydrolyzes adenylated double-strand breaks
strengthens the possibility of a role in double-strand break
repair, in agreement with the observed mild sensitivity to ion-
izing radiation in patient-derived Aptx-deficient cell lines (4).
Aprataxin is a member of the HIT superfamily of nucleotide
hydrolases and transferases (15).Mutation of the histidine triad
motif completely abolishes the ability of Aprataxin to hydrolyze
AMP-DNA (8), and inactivating disease-associated mutations
of Aptx are largely confined to the HIT domain (10). Other
domains of Aprataxin appear to play important, though non-
critical roles, in protein association, substrate recognition, and
catalytic activity. First, the N-terminal FHA domain is neces-
sary for interaction with XRCC1 and XRCC4, but not for
hydrolase activity (11). Second, we found that mutation of the
C-terminal zinc finger motif led to reduced AMP-DNA hydro-
lase activity, and this defect was shown to be due to inefficient
binding of the DNA adenylates. Consistent with these results,
disease-associated Aptx truncations that delete the C-terminal
domain exhibit anAOA1phenotype, although this is somewhat
milder than that observed with mutations in the HIT domain
(3). We suggest that the Aprataxin zinc finger domain provides
stabilizing contacts that lock the enzyme onto a high affinity
AMP-DNA target site.
It is known that abortive ligation reactions at dirty DNA
breaks produced by reactive oxidative species lead to the accu-
mulation of adenylated DNA intermediates in the absence of
Aptx activity (8). Here, we show that abortive ligation interme-
diates thatmight arise during base excision repair can also serve
as substrates for Aptx. Abasic nicks with 3OH and 5 deoxyri-
bosephosphate termini are created by the action of monofunc-
tional DNA glycosylases, followed by AP endonuclease 1 inci-
sion at the 5-side of the excised base (14).We found that while
abasic nicks can be ligated by DNA ligase III-XRCC1, a signifi-
cant fraction were converted into adenylated abasic nicks
through abortive ligation. Aptx was able to resolve these adeny-
lated abasic nicks, whereas the dRP lyase activity DNA poly-
merase  could not. Furthermore, we were unable to detect any
AMP hydrolysis activity in Aptx-deficient cell extracts. Thus,
Aptx may be important to channel abortive ligation intermedi-
ates back into the scheduled repair mechanism in which DNA
FIGURE 5. Actions of Aprataxin with adenylated abasic nick substrates. A, human DNA ligase III-XRCC1 complex promotes the ligation of abasic nicked
DNAs, but abortive ligation reactions give rise to adenylated products. Ligation reactions, containing 3-32P-labeled abasic nicked or control nicked DNA
substrate,withT4DNA ligaseorhumanDNA ligase III-XRCC1,were incubated for 1min (lanes 2,4,6, and8) or 2min (lanes 3,5,8, and10). Productswereanalyzed
by denaturing PAGE and detected by autoradiography. The abasic 18-mer and the ligation product containing the abasic 18-mer are marked with dRP.
B, ligation reactions containing humanDNA ligase III-XRCC1 and abasic nickedDNA substrate were incubated for 1min.Wild-type Aptx (10 nM) was present in
the reaction shown in lane 3. Products were analyzed by denaturing PAGE and detected by autoradiography. C, hydrolysis reactions containedwild-type Aptx
andadenylatednickedor abasic nickedDNAas indicated. Productswere analyzedbydenaturingPAGEanddetectedbyautoradiography.D, adenylatedabasic
nicks (50 nM) were treated with whole cell extracts (1g of total protein) from normal and AOA1 lymphoblastoid human cell lines (Ap1 and Ap3) as indicated.
Incubation was for 5 min at 37 °C, and the products were analyzed by denaturing PAGE and detected by autoradiography. E, reactions contained adenylated
abasic nicked DNA (50 nM) with wild-type Aptx (2 nM) or polymerase  (20 nM) as indicated in 50 mM Tris-HCl, pH 8.8, 10 mM MgCl2,10 mM KCl, 1 mM DTT, 1%
glycerol, 20M each of dCTP, dGTP, dATP, and dTTP. Incubationwas for 15min at 37 °C, and the products were analyzed by denaturing PAGE and detected by
autoradiography.
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polymerase  will promote gap filling and 5-dRP removal.
Finally, DNA ligase III-XRCC1will seal the processed nick (Fig.
6). The fact that Aptx-deficient cell lines have been shown to be
sensitive to MMS (6), which leads to the formation of lesions
that are acted upon by the monofunctional DNA glycosylase
MPG, lends support to an involvement in BER.
The repair pathway described above is referred to as “short
patch repair”, as it leads to a repair patch of a single nucleotide and
is the preferred mechanism of BER. Alternatively, repair may
involve “long patch repair” mechanisms in which DNA polymer-
ases  or  take over from polymerase  at the gap-filling step and
continue DNA synthesis, thereby displacing the strand carrying
the dRP residue (14, 16). In this subpathway, a 5-flap is created
and subsequently removedby the structure-specific endonuclease
FEN1. Long patch repair mechanisms may be utilized to remove
any blocking 5-adenylates, and provide an alternative to Aptx
actions. However, long patch repair is thought to be activemainly
during S-phase (16–18) and involves proliferating cell nuclear
antigen, DNApolymerases  and , DNA ligase I, and FEN1, all of
which function during DNA replication. This cell cycle bias could
be significant with regard to AOA1, as long patch repair may not
be readily available in non-proliferating neuronal cells. The
dependence on Aptx may be further exacerbated by the high rate
of oxygenmetabolism in the brain, given that reactive oxygen spe-
cies contribute to base damages that can lead to the formation of
abasic nicks (19). It is therefore likely that in the absence of Aptx
the additional accumulationofDNAadenylates at incisedAP sites
will contribute to the genotoxic load faced by the cell.
In conclusion, our results providenew insight into the substrate
specificity ofAptx.Wehave shown thatDNAadenylates induplex
DNA are the primary substrates for Aptx and that the C-terminal
zinc finger isakeydeterminant for thebindingofadenylatedDNA.
Furthermore, our biochemical studies lead us to suggest thatAptx
activity may provide a proofreading mechanism during ligation
that is utilized by several distinct DNA repair pathways, including
single-strand break repair, double-strand break repair, and BER.
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FIGURE 6. Schematic diagram of base excision repair and role of
Aprataxin. The damaged base (black) is removed by a monofunctional gly-
cosylase to produce an abasic site (AP site). AP endonuclease 1 incises at the
5-side of theAP site to generate an abasic nickwith a deoxyribosephosphate
residue (marked dRP) at the 5 terminus. Untimely ligation reactions may be
successful or could be abortive, leading to the formation of an adenylated
abasic nick. Aprataxin can efficiently remove the adenylate to restore the
abasic nick and allow subsequent re-entry into the BER pathway.
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